About EDUpub Publisher

EDUpub Publisher is a unique international publisher for publishing online open-access research contents of the highest quality and significance in all areas of academic research and technology. Open access ensures accessibility to a wide range of audience by allowing an individual to have unrestricted use and reuse of published content as per CC license policy provided on each publication’s homepage. As an open access publisher, we are providing an opportunity for global researchers to get involved in updating themselves with the ongoing research. We publish international, open access, peer-reviewed academic journals, Books, Thesis, Dissertation, Conference Proceedings, Abstract Book, Conference Special Issue, Preprints, etc. Whether you are an Inspiring teacher, scientist, creative aspirants, curious students or researcher; we are cordially inviting you to browse our website and learn about ongoing researches in the field. In order to maintain manuscript quality, each manuscript submitted shall undergo peer review process. All the Journal with EDUpub Publisher follows a rigorous peer-review process to retain high standards of published articles.

EDUpub Logo

EDUpub offers scholarly book publication with ISBN and DOI. As an author, it is important that you take time to consider the right publisher and right book’s category for your important publication. The author will retain exclusive copyright and grant non-exclusive publishing and commercial right to AIJR Publisher with open access end-user license. Books will get promoted to potential readers worldwide by online distribution through EDUpub publishing platform and other open access archiving services.

Currently, AIJR will consider online publication for the following types of books directly from the author(s)-

• Academic Thesis / Dissertation
• Edited Volumes/Books 
• Monographs (
• Project Reports as Book (Requires NOC from funding agency)

EDUpub also publish following types of books from conference organizer-

• Conference Proceedings
• Conference Abstract Book
  

Benefits of Publishing book with EDUpub

• Peer-Reviewed: We are publishing refereed books, our all publications are peer-reviewed.
• Open Access: All books are published with free access to everybody worldwide, No hidden fees.
• ISBN: Each publication will get assigned an ISBN number and registered in the international database.
• Retain copyright: The author retains copyright and granted non-exclusive publishing right to the EDUpub Publisher. Author(s) are free to disseminate their published article, make copies for any use, and/or deposit in any repository or archive they like by linking to the original published article.
• Support the community: By publishing your book with us you support the EDUpub Publisher and enable youths to read your work.
• Be read: Due to our books are free to everybody, more people access the books and cite you.
• Print on Demand: We also offer a print version (with separate print ISBN) on demand, contact us for a quote.

How to Get Book Published 

Beijing has started mass vaccination program amid concerns regarding its efficacy owing to the absence of phase 3 clinical trial data.

Beijing Municipal Health Commission said at a news conference on Sunday that more than 70000 people in 220 inoculation venues across Beijing have received the first dose of COVID-19 vaccine since the city began administering the jab among specific groups of people with higher infection risks on the first day of new year 2021. There are, however, strong concerns in the global medical community about the safety and efficacy of the Chinese vaccines. Chinese Foreign Ministry last week said, phase three trials are going smoothly, without giving a clear response on when China is planning to release the phase 3 clinical trial data.

China announced Thursday that it had granted conditional marketing authorization to its first self-developed COVID-19 vaccine. The inactivated vaccine was developed by the Beijing Biological Products Institute Co. Ltd. under Sinopharm’s subsidiary China National Biotec Group (CNBG).

The conditional approval announcement for the CNBG vaccine came a day after the National Medical Products Administration said the vaccine showed 79.3% efficacy based on interim results from the Phase 3 clinical trials.
China’s vaccines are part of its diplomacy, shoring up ties with dozens of poorer nations facing the challenges of manufacturing, distributing and administering billions of doses.

China has also agreed to supply its vaccine to Covax, a World Health Organization-backed effort to provide a coronavirus vaccine to developing nations. But there has been little information about how the Chinese vaccines have performed in the final stage -phase 3 clinical trials. Meanwhile, some U.S. and European companies have published data on the safety and efficacy of their shots and started to deploy them.

Chinese vaccine manufacturers were initially at the forefront of the research, however, U.S. companies raced ahead to carry out the vital third-stage clinical trials. As per reports, Chinese companies now have third-phase trials running in at least 16 nations, with state-backed China National Biotec Group Co. testing from Argentina to Morocco; Sinovac Biotech Ltd. enlisting Brazil, Turkey and the Philippines among others; and CanSino Biologics Inc. testing in Pakistan, Mexico and Saudi Arabia. So far, there hasn’t had any systematic data available.

Other provinces are also rolling out mass vaccination programs. Meanwhile, as per local media reports, quoting an online poll in Hong Kong, around 41 per cent of respondents expressed reservations about getting vaccinated while only 8 per cent said they would “definitely” get the shots. The top three reasons cited by those who did not want to take vaccines were “doubts over the effectiveness”, “worries about side effects” and “no choice of the manufacturer of the vaccine that is to be taken”.

The National Health Commission (NHC) said the data on safety and efficacy collected so far in the Phase 3 clinical trials of the CNBG vaccine is better than expected. The results are better than the 50% standard set by the World Health Organization (WHO) and Chinese authorities, but are far below the more than 90% efficacy shown by the mRNA vaccines developed by Pfizer/BioNtech and Moderna, Inc.

Since July, China has vaccinated more than a million Chinese unofficially with three vaccines under emergency use authorization despite the vaccines’ safety and efficacy not being confirmed by Phase 3 clinical trials. Despite the absence of phase 3 trial data, NHC said the emergency use of the three COVID-19 vaccines showed no severe adverse effects on those inoculated. 

In Bihar, all educational institutions will be opened from today with strict compliance of covid protocols. Schools from Class 9th onwards, colleges and coaching institutes are permitted to allow only 50 percent of students. These institutions were facing closure from March last year due to corona pandemic. They have been asked to call students in batches on alternative days.
 
Principal Secretary Education Sanjay Kumar said students will be allowed to attend the physical classes only after the written consent of their parents or guardians. The educational institutions have to make arrangements for online classes for those who do not wish to attend the physical classes.
 
The government has also released preventive measures to contain the spread of Covid-19 in all government and private schools and higher educational institutions. Temperature of staff and students will be checked before they enter the premises. There should be arrangement for hand sanitizers, liquid soaps and digital thermometer. Two masks will be given to each student of the educational institutions.

A bird flu warning has been sounded in Rajasthan after the confirmation of its virus in dead crows in Jhalawar district. Animal Husbandry Department has set up a state-level control room and sent its teams to the district for effective monitoring.

Yesterday, seven crows were found dead at the iconic Jal Mahal in Jaipur, taking the toll to 252 in the state. Principal Secretary, Animal Husbandry, Kunji Lal Meena said that the deaths due to bird flu have been mainly reported among crows, with most of them from the Kota and Jodhpur divisions. He said, the virus is dangerous and necessary guidelines have been issued.

All field officers and poultry farm owners have been asked to remain vigilant. Effective monitoring is ensured at all sites, especially in wetlands, Sambhar Lake and Kaila Devi bird sanctuary. Mr Meena said, the crow deaths were reported on December 25 in Jhalawar.

Their samples were sent to the National Institute of High-Security Animal Diseases (NIHSAD) in Bhopal and the bird flu virus was detected. So far, the death of 100 crows has been reported from Jhalawar, 72 from Baran, 47 from Kota, 19 from Pali, seven from Jodhpur and seven from Jaipur.

Medical experts have welcomed the government’s decision to approve two Corona virus vaccines for emergency use in the country.  

All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria has lauded the work done by Indian laboratories in making indigenous vaccines. He said, the research has been done in the country and it’s truly an Indian vaccine. Dr Guleria said, these vaccines are cost-effective and easy to administer as they can be stored at temperatures between 2 to 8 degrees Celsius.

Lieutenant General Ved Chaturvedi of Sir Gangaram Hospital, Delhi has said that the Corona vaccines approved by government are fully safe.

Dr. Naresh Trehan of Medanta Medicity has said that the vaccine will be fully effective after its two dosages.

World Health Organisation has welcomed India’s decision to allow the use of two COVID-19 vaccines. Its Regional Director Dr Poonam Khetrapal Singh said, WHO welcomes the first emergency use authorization given to COVID-19 vaccine in the WHO South-East Asia Region. It will help intensify and strengthen the fight against COVID-19 pandemic in the Region.

Drugs Controller General of India (DCGI) has given its approval for restricted use of two Covid-19 vaccines – Serum Institute of India’s, Covishield and Bharat Biotech’s Covaxin in emergency situation. The announcement for granting permission to these two vaccines was made by the Drug Controller General of India VG Somani during a press conference yesterday. 

Government has said that the Covid-19 vaccines introduced in India will be as effective as any vaccine developed by other countries.

The Health Ministry has come out with a series of frequently asked questions about COVID-19 vaccine on various aspects. The Ministry said, various phases of vaccine trials are undertaken to ensure its safety and efficacy. In the initial phase Covid vaccine will be provided to the selected priority groups as they are at higher risk.

The first group who will be vaccinated includes healthcare and frontline workers. The second group to receive COVID 19 vaccine will be persons, over 50 years of age and persons under 50 years with comorbid conditions. The Ministry has said that vaccination for COVID-19 is voluntary. However, it has advised to receive the complete schedule of COVID-19 vaccine for protecting one-self against this disease. This will also limit the spread of this disease to the close contacts including family members, friends, relatives and co-workers.

The next round of talks between the Central Government and farmer unions will be held in New Delhi today. Earlier, 6th round of talks between Government and Farmer Unions was held on 30th of last month.
 
During the meeting, Agriculture Minister Narendra Singh Tomar had assured the Farmer leaders that the government is committed to solving their problems and both sides need to take steps forward to arrive at an amicable solution. He said, consensus on two out of four issues was reached during the meeting. Mr Tomar said the first issue was an ordinance related to the Environment and the second was on Electricity Act.
 
Mr Tomar had assured the Farmer Unions that MSP and the Mandi system will continue like before. The demand of the Farmer Unions for an MSP law and the difference between MSP and market rates for agricultural produce will be referred to a committee when it is constituted.
 
On the Unions’ demand for the repeal of Farm Laws the Minister had said that this too can be referred to a committee which will study the constitutional validity and propriety keeping in mind the welfare of farmers. Mr Tomar had assured the farmers that government has an open mind and is willing to resolve all issues with clear intentions. Agriculture Minister asked the Union leaders to put forward their proposals which the government will study and discuss. He complimented the Farmer Unions for keeping the agitation disciplined and peaceful. The Minister had assured that the government is taking all possible steps for the welfare of farmers.

Prime Minister Narendra Modi will deliver the inaugural address at the National Metrology Conclave today through video conferencing.

He will also dedicate National Atomic Timescale and Bhartiya Nirdeshak Dravya to the nation and lay the foundation stone of the National Environmental Standards Laboratory. Science and Technology Minister Dr. Harsh Vardhan will also be present on the occasion.

The National Atomic Timescale generates Indian Standard Time with an accuracy of 2.8 nanosecond. Bhartiya Nirdeshak Dravya is supporting testing and calibration of laboratories for quality assurance, at par with international standards.

The National Environmental Standards Laboratory will aid self-reliance in the certification of ambient air and industrial emission monitoring equipment.

National Metrology Conclave 2021 is being organised by Council of Scientific and Industrial Research-National Physical Laboratory, New Delhi which is entering into its 75th year of inception. The theme of the conclave is Metrology for the Inclusive Growth of the Nation.

Prime Minister Narendra Modi will deliver the inaugural address at the National Metrology Conclave tomorrow through video conferencing. He will also dedicate National Atomic Timescale and Bhartiya Nirdeshak Dravya to the nation and lay the foundation stone of the National Environmental Standards Laboratory.

Union Minister Dr. Harsh Vardhan will also be present on the occasion.

The National Atomic Timescale generates Indian Standard Time with an accuracy of 2.8 nanosecond. Bhartiya Nirdeshak Dravya is supporting testing and calibration of laboratories for quality assurance, at par with international standards.

The National Environmental Standards Laboratory will aid self-reliance in the certification of ambient air and industrial emission monitoring equipment.

National Metrology Conclave 2021 is being organised by Council of Scientific and Industrial Research-National Physical Laboratory, CSIR-NPL New Delhi which is entering into its 75th year of inception.

The theme of the conclave is Metrology for the Inclusive Growth of the Nation.

51st International Film Festival of India (IFFI) will open on 16th January, with the Indian premiere of the movie ‘Another Round’ by Thomas Vinterberg.

The movie starring Cannes Best Actor Award winner Mads Mikkelsen is among a star-studded line up of movies being showcased at IFFI. The movie is also Denmark’s official entry to the Oscars.

The festival will also witness the World Premier of ‘Mehrunisa’. The film by Sandeep Kumar will premier mid-fest.

The festival will close on 24th January with the India Premier of the historical drama ‘Wife of a Spy’ by Kiyoshi Kurosawa.

51st IFFI is being organised from 16th to 24th January in Goa.

This edition is being organised in a hybrid mode for the first time and will comprise both online and in-person experience. The festival will be loaded with a line-up of famous movies with a total of 224 films from across the globe.

This includes 21 non-feature films and 26 feature films under the Indian Panorama section. Media registration for the festival has opened recently and is available till 10th January.

In yet another matter of pride for India, Prime Minister Narendra Modi has been rated as the most popular head of state by an American research firm.

According to research firm, Morning Consult, over 75 per cent people approved Mr Modi, while 20 per cent disapproved, putting his net approval rating at 55 per cent. This is higher than any other world leader.

The survey was conducted by the American firm in 13 countries including the US, Japan and Brazil.

Home minister Amit Shah has hailed the Prime Minister for the global praise he is receiving in the backdrop of the Covid-19 fight that Mr Modi led in India. Mr Shah said, entire world is praising Mr Modi for the way he is handling COVID-19 global pandemic, taking care of Indians and helping the world community in such challenging times.

BJP President JP Nadda said, the latest rating is a testimony of the Prime Minister’s able leadership and hard work and is a thing of pride for all citizens of the country.

Information and Broadcasting Minister Prakash Javadekar also congratulated the Prime Minister and said that it is a matter of pride for the country.

Meanwhile, Prime Minister has shared a poem written by him, along with a video. The poem is titled “Abhi toh Suraj Uga Hai (The Sun has just Risen)”. Let’s listen to the poem:

India continues to scale several peaks in its fight against the COVID19 pandemic. As the country readies for the COVID-19 vaccine roll-out, Ministry of Health and Family Welfare has been pro-actively involved in the preparations for this roll-out over the past couple of months to ensure that the preparations for roll-out of COVID-19 vaccine are on track, in close collaboration with the States, UTs and other stakeholders.

In a massive nation-wide exercise yesterday, an end-to-end mock drill on the vaccine administration was conducted in all States and UTs at 286 session sites spread across 125 districts. Each District conducted the dry run at three sites or more which included a public health facility District Hospital or Medical College, Private Health Facility and rural or urban outreach sites.

All the State and District officials were trained on the Operational Guidelines and  for conducting the dry-run. This dry run was aimed at testing the laid out mechanisms for COVID-19 vaccination roll-out in the health system and to assess operational feasibility of using Co-WIN application in the field environment for planning, implementation and reporting at the block, district and state level.

The dry run was also conducted to familiarize the State, District, Block and Hospital level officers on all aspects of COVID-19 roll out.

The States and UTs conducted the dry run from 9 am across the country, in a seamless manner. The activities starting from beneficiary data upload, session site allocation and micro planning, vaccine allocation, session site management with test beneficiaries, reporting mechanism etc were covered in this one day dry run to execute the nearest possible simulation of the actual day.

The preparation to handle any Adverse Events Following Immunization at all session sites and functionality of the Call Centers was also tested.

The dry run was supervised by the District collectors. This dry run ended with debriefing meetings at district and the state level to discuss the issues and challenges encountered during the day. The Health Ministry was in constant touch with the States throughout the day to seek feedback on their experience.

The States and UTs have expressed complete satisfaction on the successful conduct of the dry run which included the operational process and its linkages with the Co-WIN Software.

The Co-WIN software has been developed by Health Ministry for real time information of vaccine stocks, their storage temperature and individualized tracking of beneficiaries for COVID-19 vaccine.

This software will assist the programme managers across all levels through automated session allocation for pre-registered beneficiaries, their verification and a digital certificate will be generated upon successful completion of the vaccine schedule.  More than 75 lakh beneficiaries have been registered on Co-WIN software till date.

The cold chain infrastructure is sufficient to ensure last mile delivery of COVID-19 vaccine in a temperature controlled environment across the country. Sufficient supplies of syringes and other logistics have also been ensured to begin COVID-19 vaccination drive.

Around 1 lakh 14 thousand one hundred vaccinators have been trained on the process to be followed at the vaccination sites which includes beneficiary verification, vaccination, cold chain and logistics management, Bio-Medical Waste management, Adverse Events Following Immunization  management and uploading the information on Co-WIN software.

The entire operational planning and IT platform has been field tested in four states which include Andhra Pradesh, Assam, Punjab and Gujarat on 28th and 29th December 2020 and on the basis of feedback received, minor enhancements have been made in the IT system.

India continues to scale several peaks in its fight against the COVID19 pandemic. As the country readies for the COVID-19 vaccine roll-out, Ministry of Health and Family Welfare has been pro-actively involved in the preparations for this roll-out over the past couple of months to ensure that the preparations for roll-out of COVID-19 vaccine are on track, in close collaboration with the States, UTs and other stakeholders.

In a massive nation-wide exercise yesterday, an end-to-end mock drill on the vaccine administration was conducted in all States and UTs at 286 session sites spread across 125 districts. Each District conducted the dry run at three sites or more which included a public health facility District Hospital or Medical College, Private Health Facility and rural or urban outreach sites.

All the State and District officials were trained on the Operational Guidelines and  for conducting the dry-run. This dry run was aimed at testing the laid out mechanisms for COVID-19 vaccination roll-out in the health system and to assess operational feasibility of using Co-WIN application in the field environment for planning, implementation and reporting at the block, district and state level.

The dry run was also conducted to familiarize the State, District, Block and Hospital level officers on all aspects of COVID-19 roll out.

The States and UTs conducted the dry run from 9 am across the country, in a seamless manner. The activities starting from beneficiary data upload, session site allocation and micro planning, vaccine allocation, session site management with test beneficiaries, reporting mechanism etc were covered in this one day dry run to execute the nearest possible simulation of the actual day.

The preparation to handle any Adverse Events Following Immunization at all session sites and functionality of the Call Centers was also tested.

The dry run was supervised by the District collectors. This dry run ended with debriefing meetings at district and the state level to discuss the issues and challenges encountered during the day. The Health Ministry was in constant touch with the States throughout the day to seek feedback on their experience.

The States and UTs have expressed complete satisfaction on the successful conduct of the dry run which included the operational process and its linkages with the Co-WIN Software.

The Co-WIN software has been developed by Health Ministry for real time information of vaccine stocks, their storage temperature and individualized tracking of beneficiaries for COVID-19 vaccine.

This software will assist the programme managers across all levels through automated session allocation for pre-registered beneficiaries, their verification and a digital certificate will be generated upon successful completion of the vaccine schedule.  More than 75 lakh beneficiaries have been registered on Co-WIN software till date.

The cold chain infrastructure is sufficient to ensure last mile delivery of COVID-19 vaccine in a temperature controlled environment across the country. Sufficient supplies of syringes and other logistics have also been ensured to begin COVID-19 vaccination drive.

Around 1 lakh 14 thousand one hundred vaccinators have been trained on the process to be followed at the vaccination sites which includes beneficiary verification, vaccination, cold chain and logistics management, Bio-Medical Waste management, Adverse Events Following Immunization  management and uploading the information on Co-WIN software.

The entire operational planning and IT platform has been field tested in four states which include Andhra Pradesh, Assam, Punjab and Gujarat on 28th and 29th December 2020 and on the basis of feedback received, minor enhancements have been made in the IT system.

Prime Minister Narendra Modi has called upon students to discover new and innovative solutions to make local products global. Addressing the students and faculty of IIM Sambalpur, Odisha, he said, IIMs can work as a bridge between local products and international collaboration for Atmanirbhar Bharat.

Mr Modi said, the vast talent pool of the IIMs both within and outside the country can help realise the goals of globalising brand India. Mr Modi said, today’s startups are the multinational companies of tomorrow.

Prime Minister yesterday laid the foundation stone of the permanent campus of IIM Sambalpur, via video conferencing.

Prime Minister said that the real task of the management is not just to manage the institutions but also to improve the lives of the people. Mr Modi said, those who are left behind in the race of development must also be included in the journey towards growth.